Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about PROTAGONIST THERAPEUTICS, INC.
10/26Protagonist Therapeutics Gets $7.5 Million Milestone Payment from Johnson & Johnson's J..
MT
10/26Protagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
PR
10/26Protagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
CI
10/13PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/13NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
10/12PROTAGONIST THERAPEUTICS : Shares Drop on Elevated Volume
MT
10/12PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/12WALL STREET STOCK EXCHANGE : It's just a period of market normalization
10/12PROTAGONIST THERAPEUTICS : SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $..
MT
10/12PROTAGONIST THERAPEUTICS : JPMorgan Upgrades Protagonist Therapeutics to Overweight From N..
MT
10/12PROTAGONIST THERAPEUTICS : to Present at the Jefferies Next Generation IBD Therapeutics Su..
PR
10/12ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex...
10/11Health Care Stocks Sliding in Late Monday Trading
MT
10/11Health Care Stocks Drifting Monday as Biotechs Climb
MT
10/11Top Midday Gainers
MT
10/11PROTAGONIST THERAPEUTICS : Northland Capital Markets Upgrades Protagonist Therapeutics to ..
MT
10/11Health Care Stocks Trade Lower Premarket Monday
MT
10/11Wall Street Declines on Soaring Energy Prices
MT
10/11PROTAGONIST THERAPEUTICS : Health Care
MT
10/11PROTAGONIST THERAPEUTICS : Says FDA Lifts Clinical Hold on Rusfertide Trials; Shares Surge..
MT
10/11Top Premarket Gainers
MT
10/11PROTAGONIST THERAPEUTICS : Announces Removal of FDA Clinical Hold on the Rusfertide Clinic..
PR
10/11Protagonist Therapeutics Announces Removal of Fda Clinical Hold on the Rusfertide Clini..
CI
10/11Protagonist Therapeutics' Clinical Hold on Rusfertide Lifted
DJ
10/05PROTAGONIST THERAPEUTICS : Announces Data from Phase 2 Rusfertide Study in Hereditary Hemo..
AQ
10/04ANNEXON : Names Larry Mattheakis as Chief Scientific Officer
MT
09/22PROTAGONIST ALERT : Bragar Eagel & Squire, P.C. is Investigating Protagonist on Behalf of ..
BU
09/22PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
09/20Top Midday Decliners
MT
09/20PROTAGONIST THERAPEUTICS : Reports FDA Clinical Hold on Rusfertide Clinical Development Pr..
AQ
09/20PROTAGONIST THERAPEUTICS : SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $..
MT
09/20PROTAGONIST THERAPEUTICS : HC Wainwright Adjusts Protagonist Therapeutics' Price Target to..
MT
09/20PROTAGONIST THERAPEUTICS : JPMorgan Downgrades Protagonist Therapeutics to Neutral From Ov..
MT
09/20PROTAGONIST THERAPEUTICS' : Clinical Studies of Rusfertide Placed on Hold by FDA -- Shares..
MT
09/17PROTAGONIST THERAPEUTICS : Reports FDA Clinical Hold on Rusfertide Clinical Development Pr..
PU
09/17PROTAGONIST THERAPEUTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/17NASDAQ 100 : Top Midday Decliners
MT
09/17PROTAGONIST THERAPEUTICS : Northland Capital Downgrades Protagonist Therapeutics to Market..
MT
09/17Wall Street Futures in Holding Pattern Ahead of Fed Meeting Next Week
MT
09/17Health Care Stocks Mixed Premarket Friday
MT
09/17PROTAGONIST THERAPEUTICS : Health Care
MT
09/17Protagonist Therapeutics Shares Tumble as FDA Puts Rusfertide on Hold
DJ
09/17Top Premarket Decliners
MT
09/17PROTAGONIST THERAPEUTICS' : Clinical Studies of Rusfertide Placed on Hold by FDA; Shares F..
MT
09/17PROTAGONIST THERAPEUTICS : Reports FDA Clinical Hold on Rusfertide Clinical Development Pr..
PR
09/17Protagonist Therapeutics Reports FDA Clinical Hold on Rusfertide Clinical Development P..
CI
09/17Protagonist Drug Studies Placed on FDA Hold
DJ
09/15PROTAGONIST THERAPEUTICS : Reports Granting of Inducement Awards
PR
09/07PROTAGONIST THERAPEUTICS : Appoints Scott Plevy, M.D., Executive Vice President and Therap..
PR
09/07Protagonist Therapeutics Appoints Scott Plevy, M.D., Executive Vice President and Thera..
CI
08/16Certain Common Stock of Protagonist Therapeutics, Inc. are subject to a Lock-Up Agreeme..
CI
08/16Certain Options of Protagonist Therapeutics, Inc. are subject to a Lock-Up Agreement En..
CI
08/16Certain Warrants of Protagonist Therapeutics, Inc. are subject to a Lock-Up Agreement E..
CI
08/10PROTAGONIST THERAPEUTICS : Resolves Contract Dispute With Zealand Pharma
MT
08/10PROTAGONIST THERAPEUTICS : Announces Resolution of Contract Dispute with Zealand Pharma
PR
08/10PROTAGONIST THERAPEUTICS, INC : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/06PROTAGONIST THERAPEUTICS : HC Wainwright Adjusts Protagonist Therapeutics' Price Target to..
MT
08/05PROTAGONIST THERAPEUTICS : SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $..
MT
08/04PROTAGONIST THERAPEUTICS : Q2 Earnings Snapshot
AQ
08/04PROTAGONIST THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Recent Compan..
PU
08/04PROTAGONIST THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
08/04Protagonist Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
CI
08/04PROTAGONIST THERAPEUTICS, INC : Results of Operations and Financial Condition, Financial S..
AQ
08/04PROTAGONIST THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Recent Compan..
PR
07/30PROTAGONIST THERAPEUTICS : Piper Sandler Adjusts Protagonist Therapeutics' Price Target to..
MT
07/28PROTAGONIST THERAPEUTICS, INC : Entry into a Material Definitive Agreement (form 8-K)
AQ
07/28PROTAGONIST THERAPEUTICS : Announces Amendment of Agreement with Janssen Biotech for the C..
PR
07/28Protagonist Therapeutics, Inc. Announces Amendment of Agreement with Janssen Biotech, I..
CI
06/30PROTAGONIST THERAPEUTICS : Reports Granting of Inducement Award
PR
06/21PROTAGONIST THERAPEUTICS INC. : Announces Closing of $132.2 Million Public Offering of Com..
AQ
06/18PROTAGONIST THERAPEUTICS' : Underwriters Exercise Overallotment Options, Boosting Public O..
MT
06/18PROTAGONIST THERAPEUTICS, INC. : Announces Closing of $132.2 Million Public Offering of Co..
PR
06/18PROTAGONIST THERAPEUTICS : HC Wainwright Adjusts Protagonist Therapeutics PT to $50 From $..
MT
06/17PROTAGONIST THERAPEUTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/16PROTAGONIST THERAPEUTICS : Prices Upsized Offering at $37.75 Per Share
MT
1  2  3  4  5  6Next
Upcoming event on PROTAGONIST THERAPEUTICS, INC.
11/10/21